For Research Use Only – Not for Human Consumption. For Research Use Only. Not for Human Consumption. Not for diagnostic, therapeutic or medical use. Statements have not been evaluated by the FDA.
Selank Nasal Format: Same Peptide, Different Presentation
Tap to zoom
Key points
- The molecule is Selank, described in our main Selank overview.
- Evidence is small, mostly Russian studies; the nasal format does not change that.
- Not FDA-approved; no dosing, efficacy or administration claims.
What it is
This card is about the same heptapeptide as the standard Selank card (about 752 daltons), shown in an intranasal catalog format.
How researchers study it
The molecular research themes are the same: neuropeptide, stress-response and GABA-related models. The card contrasts presentation forms in general terms only.
What the evidence shows
The studies behind Selank are small and mostly come from Russia. A change of format does not add evidence, and this card does not claim any effect.
Regulatory status
Selank is approved in Russia but not by the FDA or in the United States. This is educational format literacy, not prescribing information, and it contains no use instructions.
